SBI PHARMACEUTICALS CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Subsidiary
- Established
- 2008-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.sbipharma.co.jp
Pilot Study to Evaluate the Safety and Efficacy of 5-ALA-SFC in Type II Diabetes
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Drug: 5-ALA-SFCDrug: Placebo
- First Posted Date
- 2015-06-25
- Last Posted Date
- 2018-05-22
- Lead Sponsor
- SBI Pharmaceuticals Co, Ltd.
- Target Recruit Count
- 53
- Registration Number
- NCT02481141
© Copyright 2025. All Rights Reserved by MedPath